# Barclays plc: overview BCS · NYSE · CIK 312069 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bcs.md) · [Financials](/companies/bcs/financials.md) · [Filings](/companies/bcs/filings.md) · [Insiders](/companies/bcs/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $bn | [9.8](/filings/0000312069-24-000026.md) | [9.5](/filings/0000312069-25-000114.md) | [10.0](/filings/0000312069-26-000004.md) | [10.7](/filings/0000312069-26-000004.md) | [11.1](/filings/0000312069-26-000004.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [231.5%](/filings/0000312069-22-000085.md) | not reported | not reported | not reported | not reported | | Net margin | % | [71.8%](/filings/0000312069-24-000026.md) | [62.4%](/filings/0000312069-25-000114.md) | [52.7%](/filings/0000312069-26-000004.md) | [58.9%](/filings/0000312069-26-000004.md) | [64.6%](/filings/0000312069-26-000004.md) | | Diluted EPS | $ per share | [0.36](/filings/0000312069-24-000026.md) | [0.30](/filings/0000312069-25-000114.md) | [0.27](/filings/0000312069-26-000004.md) | [0.35](/filings/0000312069-26-000004.md) | [0.42](/filings/0000312069-26-000004.md) | | Free cash flow | $bn | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Operating margin (operating income / revenue). XBRL Operating income: ifrs-full:ProfitLossFromOperatingActivities; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent; Revenue: ifrs-full:RevenueFromContractsWithCustomers. - Diluted EPS. XBRL Diluted EPS: ifrs-full:DilutedEarningsLossPerShare. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bcs/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Fisher Asset Management, LLC](/funds/850529.md) | 2026-06-30 | $2.52bn | 93,904,423 | | Added +2,453,573 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $409.9m | 15,259,089 | | Added +3,725,352 | | [NORGES BANK](/funds/1374170.md) | 2026-06-30 | $302.2m | 11,250,000 | | New +11,250,000 | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $261.8m | 9,748,660 | | Added +593,558 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $214.9m | 8,000,077 | | Reduced −691,688 | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $207.9m | 7,738,779 | | Added +377,263 | | [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $205.7m | 7,589,769 | | Added +379,157 | | [JONES FINANCIAL COMPANIES LLLP](/funds/815917.md) | 2026-06-30 | $186.9m | 6,994,045 | | Reduced −1,896,140 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $173.6m | 6,463,188 | | Added +8,696 | | [ROYAL BANK OF CANADA](/funds/1000275.md) | 2026-06-30 | $137.0m | 5,102,318 | | Reduced −65,083 | ## Recent filings [All 2,184 filings](/companies/bcs/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 07:03 ET | [6-K](/filings/0001654954-26-009117.md) | Report of a foreign private issuer, period 2026-10-23 | 0001654954-26-009117 | | 2026-10-22 | 12:45 ET | [6-K](/filings/0000312069-26-000240.md) | Report of a foreign private issuer, period 2026-09-30 | 0000312069-26-000240 | | 2026-10-22 | 06:14 ET | [6-K](/filings/0001654954-26-009079.md) | Report of a foreign private issuer, period 2026-10-22 | 0001654954-26-009079 | | 2026-10-09 | 06:30 ET | [6-K](/filings/0001654954-26-008864.md) | Report of a foreign private issuer, period 2026-10-09 | 0001654954-26-008864 | | 2026-10-01 | 06:01 ET | [6-K](/filings/0001654954-26-008684.md) | Report of a foreign private issuer, period 2026-10-01 | 0001654954-26-008684 | | 2026-09-24 | 15:23 ET | [6-K](/filings/0001654954-26-008561.md) | Report of a foreign private issuer, period 2026-09-24 | 0001654954-26-008561 | | 2026-09-24 | 12:12 ET | [6-K](/filings/0001654954-26-008556.md) | Report of a foreign private issuer, period 2026-09-24 | 0001654954-26-008556 | | 2026-09-18 | 12:45 ET | [6-K](/filings/0001654954-26-008448.md) | Report of a foreign private issuer, period 2026-09-18 | 0001654954-26-008448 | | 2026-09-11 | 12:01 ET | [6-K](/filings/0001654954-26-008287.md) | Report of a foreign private issuer, period 2026-09-11 | 0001654954-26-008287 | | 2026-09-09 | 12:38 ET | [6-K](/filings/0001654954-26-008210.md) | Report of a foreign private issuer, period 2026-09-09 | 0001654954-26-008210 | ## Latest annual report [Form 20-F for the fiscal year ended Dec 31, 2025](/filings/0000312069-26-000004.md), filed Feb 10, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 312069 - Tickers: BCS, BCLYF - Exchange: NYSE - SIC code: 6029 Commercial Banks, NEC - State of incorporation: X0 - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 08:03 ET. No prices; not investment advice.